supplies of the direct thrombin inhibitor lepirudin (Refludan) dwindle over the next few months

You'll see supplies of the direct thrombin inhibitor lepirudin (Refludan) dwindle over the next few months.

It's not a drug shortage. Lepirudin is being discontinued by the manufacturer for business reasons...not safety concerns.

This leaves just one first-line agent for preventing and treating thrombosis in patients with heparin-induced thrombocytopenia (HIT).